We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
68 hedge funds and large institutions have $72.3M invested in CASI Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 14 increasing their positions, 23 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.46% less ownership
Funds ownership: 3.8% → 3.34% (-0.46%)
20% less funds holding
Funds holding: 85 → 68 (-17)
39% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 23
43% less capital invested
Capital invested by funds: $127M → $72.3M (-$55M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 34
Holders
68
Holders Change
-17
Holders Change %
-20%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
17
Increased
14
Reduced
23
Closed
34
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$2.17M |
| 2 |
Millennium Management
New York
|
+$1.73M |
| 3 |
E
Ergoteles
New York
|
+$505K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$376K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$364K |
Top Sellers
| 1 |
BlackRock
New York
|
-$4.75M |
| 2 |
TLP
Tri Locum Partners
New York
|
-$3.6M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.51M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.42M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$971K |
